Group cognitive behavioural therapy of physical and psychological menopausal symptoms of Chinese women, delivered via Internet and mobile phone versus face to face: a protocol for a randomized non-inferiority trial

Menopause is accompanied by multidimensional alterations that affect women ’s quality of life [1]. These changes put women at high risk of health problems, both physical, such as hot flashes, night sweats and sleep disturbance [2–4], and psychological, such as anxiety [4,5]. It is estimated that, by 2030, in China, the number of women over 50 will have increased to mor e than 280 million [6]. Currently, 51%-55% of women in China experience menopause syndrome [7,8] with hot flashes (62%), fatigue (82%) [9], sleep disturbance (51%) and mood swings (40%) [10].
Source: Maturitas - Category: Primary Care Authors: Source Type: research

Related Links:

Abstract The Kronos Early Estrogen Prevention Study (KEEPS) was a randomized, double-blind, placebo-controlled trial designed to determine the effects of hormone treatments (menopausal hormone treatments [MHTs]) on the progression of carotid intima-medial thickness (CIMT) in recently menopausal women. Participants less than 3 years from menopause and without a history of overt cardiovascular disease (CVD), defined as no clinical CVD events and coronary artery calcium
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
Menopause, a nearly universal transition for women who reach midlife, is heralded by vasomotor symptoms (VMS) or hot flashes, mood disorders including depression and anxiety, sleep disruption, and genitourinary symptoms. In older women, however, mood and sleep disturbances can present independently as a function of aging, rather than menopause. Genitourinary syndrome of menopause, clinically under recognized and undertreated in aging women, is addressed in a separate chapter of this special issue.
Source: Maturitas - Category: Primary Care Authors: Source Type: research
Objective: The aim of the study was to investigate the effectiveness and safety of a new, improved herbal formula of a traditional Chinese medicine, improved Gengnianchun (I-GNC), on hot flushes, depression, anxiety, and sleep in peri- and postmenopausal women in China. Methods: A randomized, single-blind, placebo-controlled trial of peri- and postmenopausal women with Kupperman Index (KMI) scores of 15 or higher was conducted for 12 weeks. Hot flush frequencies, KMI scores, Hamilton depression scale scores, Hamilton anxiety scale scores, and Pittsburgh Sleep Quality Index scores were evaluated. Each outcome was evalu...
Source: Menopause - Category: OBGYN Tags: Original Studies Source Type: research
Conditions:   Menopause;   Depression, Anxiety;   Sleep Intervention:   Drug: Duavive 0.45Mg-20Mg Tablet Sponsors:   St. Joseph's Healthcare Hamilton;   McMaster University;   Pfizer Not yet recruiting
Source: - Category: Research Source Type: clinical trials
Hot Flashes: Clinical Summary of the ONS Guidelines™ for Cancer Treatment-Related Hot Flashes in Women With Breast Cancer and Men With Prostate Cancer. Clin J Oncol Nurs. 2020 Aug 01;24(4):430-433 Authors: Kaplan M, Mahon SM, Lubejko BG, Ginex PK Abstract Cancer-related hot flashes are often a lasting and distressing side effect of hormone-blocking therapies that are most often experienced by women with breast cancer and men with prostate cancer treated with these therapies. Hot flashes have been defined as a sensation of heat that may be accompanied by facial flushing, perspiration, chills, hea...
Source: Clinical Breast Cancer - Category: Cancer & Oncology Authors: Tags: Clin J Oncol Nurs Source Type: research
This article describes cognitive behavioral therapy (CBT) for women with problematic menopausal symptoms, and provides the evidence from clinical trials of women going through the menopause, women with breast cancer treatment-induced symptoms and women with problematic symptoms in a work context. The CBT focus is primarily on vasomotor symptoms (VMS) but it also targets stress, low mood and sleep problems. CBT is a brief therapy (four to six sessions) that is theory- and evidence-based; it is acceptable to women and effectively reduces the impact of VMS, improves sleep and has benefits to quality of life. VMS frequency is ...
Source: Climacteric - Category: Geriatrics Authors: Tags: Climacteric Source Type: research
ConclusionE2 augmented the neuroprotective effect of Ago in OVX rats via its anti-inflammatory and neurotrophic effects. The combined treatment of E2 and Ago should be further investigated as a treatment of choice for depression, anxiety, and sleep disturbances associated with menopause.
Source: Psychopharmacology - Category: Psychiatry Source Type: research
The objective of this review was to evaluate systematically the effectiveness of Lavender aromatherapy on physical and psychological symptoms in menopausal women. METHODS: A comprehensive systematic literature search in the electronic databases including the Cochrane Library, MEDLINE (PubMed), Ovid, Embase, Scopus, ProQuest, Web of science, and Google scholar, as well as Magiran, SID, and Irandoc for Persian literature review up to January 2020. All Randomized controlled trials, and quasi-experimental studies that evaluated the impact of aromatherapy with lavender alone or in combination with other aromas on physical ...
Source: Complementary Therapies in Clinical Practice - Category: Complementary Medicine Authors: Tags: Complement Ther Clin Pract Source Type: research
Discussion Fragile X syndrome (FXS) was first clinically described in 1943 by Martin-Bell and in 1969 Lubs found a fragility at the terminal end of the X chromosome. In 1991, three different research groups independently cloned the mutation for the FMR1 gene (Fragile X mental retardation type 1) which has a CGG triplet expansion. The FMR1 gene codes for the FMR protein which is a major regulator of synaptic plasticity and is expressed in the brain and spermatogonia mainly but many other tissues during fetal and early neonatal development. The number of triplets and methylation correlates with clinical expression (increased...
Source: - Category: Pediatrics Authors: Tags: Uncategorized Source Type: news
AbstractObjectiveTo estimate the prevalence of poor sleep and its risk factors for adults living in a suburban area of Shanghai with rapid urbanization.MethodsA total of 37,545 residents who were aged 20 to 74  years and from the “Peak Program,” a community-based natural population cohort study, were included. Data on demographics, lifestyle, and physical health-related factors were collected using a face-to-face questionnaire interview. Sleep quality was assessed using the Pittsburgh Sleep Quality I ndex (PSQI), and poor sleep was defined as a PSQI score above 7.ResultsThe overall mean of PSQI score was 3...
Source: Quality of Life Research - Category: Health Management Source Type: research
More News: Anxiety | Behavioural Therapy | China Health | Cognitive Behavior Therapy | Internet | Men | Menopause | Primary Care | Psychology | Sleep Disorders | Sleep Medicine | Women